CBG: Difference between revisions
From Glioblastoma Treatments
Jump to navigationJump to search
(Created page with "{{TreatmentInfo |drug_name=Cannabigerol (CBG) |FDA_approval=No (CBG is a cannabinoid compound under investigation; not FDA-approved for any condition) |used_for=Investigational use in cancer research for potential anti-tumor effects |clinical_trial_phase=Preclinical studies and early research |common_side_effects=Not specifically documented; cannabinoids are generally considered to have a favorable safety profile, but specific studies on CBG's side effects are limited |O...") |
(Updated category= to treatment_category= in TreatmentInfo template) |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 9: | Line 9: | ||
|usefulness_rating=3 | |usefulness_rating=3 | ||
|notes=Cannabigerol (CBG), a non-psychoactive cannabinoid found in the cannabis plant, has garnered attention in preclinical studies for its potential anti-cancer properties. Research has explored CBG's effects on various cancer cell lines, including its ability to induce apoptosis, inhibit cell proliferation, and potentially target cancer stem cells. While findings are promising, indicating CBG could influence pathways involved in cancer progression, conclusive evidence from human clinical trials is awaited to fully establish its efficacy and optimal use in cancer treatment. | |notes=Cannabigerol (CBG), a non-psychoactive cannabinoid found in the cannabis plant, has garnered attention in preclinical studies for its potential anti-cancer properties. Research has explored CBG's effects on various cancer cell lines, including its ability to induce apoptosis, inhibit cell proliferation, and potentially target cancer stem cells. While findings are promising, indicating CBG could influence pathways involved in cancer progression, conclusive evidence from human clinical trials is awaited to fully establish its efficacy and optimal use in cancer treatment. | ||
| | |treatment_category=Nutraceuticals | ||
|links= | |links= | ||
|toxicity_level=2 | |||
|toxicity_explanation=Cannabigerol (CBG) is generally considered safe, as it's a non-psychoactive compound found in the cannabis plant. However, specific studies on CBG’s side effects are limited owing to the fact that it is in the early stages of research. Therefore, a rating of 2 is given, indicating a low level of potential toxicity. However, definitive conclusions about its toxicity can only be made after detailed human clinical trials have been conducted. | |||
}} | }} | ||
Latest revision as of 10:28, 12 November 2024
| Property | Information |
|---|---|
| Drug Name | Cannabigerol (CBG) |
| FDA Approval | No (CBG is a cannabinoid compound under investigation; not FDA-approved for any condition) |
| Used for | Investigational use in cancer research for potential anti-tumor effects |
| Clinical Trial Phase | Preclinical studies and early research |
| Clinical Trial Explanation | Not specified |
| Common Side Effects | Not specifically documented; cannabinoids are generally considered to have a favorable safety profile, but specific studies on CBG's side effects are limited |
| OS without | Not specified |
| OS with | Not applicable; research is still in preclinical stages, focusing on cellular and animal models |
| PFS without | Not specified |
| PFS with | Not applicable; ongoing studies aim to determine the potential impacts on tumor progression |
| Usefulness Rating | 3 |
| Usefulness Explanation | Not specified |
| Toxicity Level | 2 |
| Toxicity Explanation | Cannabigerol (CBG) is generally considered safe, as it's a non-psychoactive compound found in the cannabis plant. However, specific studies on CBG’s side effects are limited owing to the fact that it is in the early stages of research. Therefore, a rating of 2 is given, indicating a low level of potential toxicity. However, definitive conclusions about its toxicity can only be made after detailed human clinical trials have been conducted. |
Notes: Cannabigerol (CBG), a non-psychoactive cannabinoid found in the cannabis plant, has garnered attention in preclinical studies for its potential anti-cancer properties. Research has explored CBG's effects on various cancer cell lines, including its ability to induce apoptosis, inhibit cell proliferation, and potentially target cancer stem cells. While findings are promising, indicating CBG could influence pathways involved in cancer progression, conclusive evidence from human clinical trials is awaited to fully establish its efficacy and optimal use in cancer treatment.
From Ben Williams Book: Not specified
Loading comments...
